In conclusion, DSS showed an antidiabetic effect via reducing hyperglycemia to attenuate AGEs expression and downregulate NF-κB-TGF-β1 pathway in diabetic glomeruli, consequently lessening ECM deposition in renal tissue. The gene discussed is TGFB1; the disease is Hyperglycemia.